Data / Crowdfunding / California / EmerRx Biopharma, LLC
EmerRx Biopharma, LLC: crowdfunding raise on MICROVENTURE MARKETPLACE INC., $25,000 to $500,000 (2026)
EmerRx Biopharma, LLC, a limited liability company in Alameda, CA, filed a Form C with the SEC on February 19, 2026 to raise $25,000 to $500,000 in CROWD NOTES through MICROVENTURE MARKETPLACE INC.. The offering closed on March 2, 2026. In its most recent fiscal year it reported $500 in revenue and a net loss of $209,439, with 4 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- emerrx.com
- Funding portal
- MICROVENTURE MARKETPLACE INC.
- Address
- 1000 ATLANTIC AVE SUITE #110, Alameda, CA 94501
- Legal form
- Limited Liability Company
- Jurisdiction
- DE
- Incorporated
- March 12, 2025
- SEC CIK
- 0002088182
Offering terms
From the amendment filed February 19, 2026.
- Security
- CROWD NOTES
- Price
- $1.00
- Target
- $25,000
- Maximum
- $500,000
- Deadline
- March 2, 2026
- Portal compensation
- AT THE CONCLUSION OF THE OFFERING, THE ISSUER SHALL PAY TO THE INTERMEDIARY A FEE CONSISTING OF FIVE PERCENT (5%) COMMISSION BASED ON THE AMOUNT OF INVESTMENTS RAISED IN THE OFFERING AND PAID UPON DISTRIBUTION OF FUNDS FROM ESCROW AT THE TIME OF CLOSING.
Financials
From the Form C-U filed March 5, 2026.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $500 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-209,439 | $0 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $80,320 | $0 | sec.gov |
| Cash | $79,620 | $0 | sec.gov |
| Accounts receivable | $700 | $0 | sec.gov |
| Short-term debt | $46,010 | $0 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| March 5, 2026 | Progress update | $25,000 | $500,000 | March 2, 2026 | $383,950 IN INVESTMENTS. PAYMENTS STILL PROCESSING; FINAL FIGURE NOT YET DETERMINED. | sec.gov |
| February 19, 2026 | Amendment | $25,000 | $500,000 | March 2, 2026 | AMENDMENT TO ATTACHED CORRECT FORM C/A FILE, TO DISCLOSE AN INVESTMENT MADE BY A RELATED PARTY OF THE COMPANY, AND TO EXTEND THE OFFERING DEADLINE. | sec.gov |
| February 19, 2026 | Amendment | $25,000 | $500,000 | March 2, 2026 | AMENDMENT TO DISCLOSE AN INVESTMENT MADE BY A RELATED PARTY OF THE COMPANY AND TO EXTEND THE OFFERING DEADLINE. | sec.gov |
| December 31, 2025 | Amendment | $25,000 | $500,000 | February 23, 2026 | AMENDMENT TO ATTACH CORRECT FORM C/A FILE AND TO INCREASE THE MAXIMUM OFFERING AMOUNT FROM $250,000 TO $500,000. | sec.gov |
| December 31, 2025 | Amendment | $25,000 | $500,000 | February 23, 2026 | AMENDMENT TO INCREASE THE MAXIMUM OFFERING AMOUNT FROM $250,000 TO $500,000. | sec.gov |
| November 19, 2025 | Amendment | $25,000 | $250,000 | February 23, 2026 | AMENDING FORM C FILING TO CORRECT OFFERING DEADLINE TO DATE SPECIFIED IN THE PREVIOUS FORM C/A FILING. | sec.gov |
| October 8, 2025 | Amendment | $25,000 | $250,000 | December 29, 2025 | AMENDMENT TO EXTEND OFFERING DEADLINE AND ALLOW FOR THE COMPANY TO ELECT TO CONDUCT INTERMEDIATE CLOSES. | sec.gov |
| September 25, 2025 | Offering | $25,000 | $250,000 | December 29, 2025 | sec.gov |
Updated March 5, 2026. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.